FdaApplication
ANDA 065391
Identifiers
- fda_app_no: ANDA065391
Properties
| Property | Value |
|---|---|
| applicant_name | WOCKHARDT BIO AG |
| application_type | ANDA |
| approval_date | 2007-04-12 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 250MG BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS |
| CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS |
| CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS |
3 products